Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in Two-Dimensional and Three-Dimensional Ultrasonic Tissue-Type Imaging of the Prostate Based on Spectrum

Feleppa1, Fair, Tsai

  • 1Riverside Research Institute, New York, New York.

Molecular Urology
|June 14, 2000
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of four surface treatment methods on the shear bond strength of resin cement to zirconia ceramics- a comparative in vitro study.

Journal of clinical and diagnostic research : JCDR·2014
Same author

Descriptor analysis of estrogen receptor β-selective ligands using 2-phenylquinoline, tetrahydrofluorenone and 3-hydroxy 6H-benzo[c]chromen-6-one scaffolds.

Journal of enzyme inhibition and medicinal chemistry·2011
Same author

Adsorption Studies of Nonionic Surfactants onto Polyvinyltoluene Microlatexes in Aqueous Medium.

Journal of colloid and interface science·2000
Same author

Supraventricular Tachycardia in Children.

Current treatment options in cardiovascular medicine·2000
Same author

Generation of large flavor mixing from radiative corrections

Physical review letters·2000
Same author

Fourth International Conference on Neoadjuvant Hormonal Therapy of Prostate Cancer: Overview Consensus Statement.

Molecular urology·2000

Radiofrequency ultrasonic spectrum analysis combined with prostate-specific antigen (PSA) levels effectively distinguishes prostate cancer. This advanced method significantly outperforms conventional imaging for biopsy guidance and treatment planning.

Area of Science:

  • Medical imaging
  • Biophysics
  • Computational biology

Background:

  • Conventional ultrasonic images often fail to detect subtle tissue differences crucial for prostate cancer diagnosis.
  • Radiofrequency (RF) ultrasonic echo signal spectrum analysis offers potential for sensing these otherwise invisible tissue variations.
  • Integrating spectral parameters with clinical variables like prostate-specific antigen (PSA) may enhance diagnostic accuracy.

Purpose of the Study:

  • To evaluate the efficacy of neural network classification using RF ultrasonic spectrum analysis and PSA levels for differentiating cancerous from noncancerous prostate tissues.
  • To compare the diagnostic performance of this novel method against conventional B-mode ultrasound imaging.
  • To explore the clinical utility of derived images for biopsy guidance, staging, and treatment planning.

Related Experiment Videos

Main Methods:

  • Spectrum analysis of RF ultrasonic echo signals was performed.
  • Neural networks were employed to classify spectral parameters and PSA values.
  • A study involving 644 biopsies from 137 patients was conducted, with histologic determination serving as the gold standard.

Main Results:

  • Neural network classification based on spectrum analysis and PSA achieved an area under the receiver-operator characteristic (ROC) curve of 0.87 ± 0.04.
  • Conventional B-mode imaging yielded an ROC curve of 0.64 ± 0.04 for level-of-suspicion assignment.
  • The developed method demonstrated significantly superior performance compared to B-mode image interpretation.

Conclusions:

  • Neural network classification integrating RF ultrasonic spectrum analysis and PSA levels is highly effective in distinguishing prostate cancer.
  • The derived color-encoded and gray-scale images offer remarkable detail, indicating significant clinical value.
  • This approach holds promise for improved biopsy guidance (2D) and comprehensive patient management (3D) in prostate cancer care.